Monomethyl Auristatin E (MMAE) / autologous neutrophil biological agents: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

2

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Early Phase 1 1

Conditions being studied

Condition	Trials
Pancreatic cancer	1
Unresectable Pancreatic Cancer	1

Recruiting trials involving Monomethyl Auristatin E (MMAE) / autologous neutrophil biological agents

A Single-Arm Investigator-Initiated Tria (IIT) Evaluating the Safety and Preliminary Efficacy of Autologous Drug-Loaded Neutrophils (NeuMed) in Patients With Unresectable Pancreatic Cancer
NCT07198659 · Phase: Early Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Monomethyl Auristatin E (MMAE) / autologous neutrophil biological agents?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.